Second, patients must meet clinical eligibility requirements and obtain prior authorization from their healthcare provider
Given the recency of FDA approval and the rapid speed at which these drugs are penetrating the market, research on their use and their side effects at the population level is in its infancy
The injectable drug, used to treat obesity and type-2 diabetes, is to be taken once a week
We used the Register of Laboratory Results for Research [14] to obtain measurements of hemoglobin A1c, plasma creatinine, albumin/creatinine ratio in urine, and estimated glomerular filtration rate (Supplementary Table 1)
These results, particularly the reduction in Pro-C3, suggest that collagen synthesis during fibrogenesis may be suppressed with survodutide treatment, supporting the development of this therapy for the treatment of NASH